期刊文献+

Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas 被引量:16

Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas
原文传递
导出
摘要 Background Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignancies in China and epidermal growth factor receptor (EGFR) is widely distributed in human epithelial cell membrane.The aim of this study was to investigate the protein overexpression and gene copy number of EGFR in ESCC,and help to identify patients who may benefit from EGFR targeted therapies.Methods Immunohistochemistry (IHC) was performed to analyze the expression of EGFR in 105 cases of ESCC,16 cases of squamous epithelial atypical hyperplasia,and 11 cases of normal esophageal tissue.Fluorescence in situ hybridization (FISH) was performed to analyze the gene copy number in 80 cases of ESCC,eight cases of squamous epithelial atypical hyperplasia,and eight samples of normal esophageal tissue.Results The IHC-positive rates of EGFR in 105 cases of ESCC,16 cases of squamous epithelial atypical hyperplasia,and 11 normal esophageal tissues were 97% (102/105),44% (7/16),and 18% (2/11) respectively.The difference in the expression of EGFR among different esophageal tissue groups had statistically significance (P 〈0.05).Among the 105 cases of ESCC,overexpression of EGFR was found in 90 cases (86%),of which 55 cases scored 3+ for EGFR staining and 35 cases scored 2+.In ESCC,the expression of EGFR was significantly correlated with depth of invasion and TNM stage (P〈0.05),but not with other parameters.The FISH-positive rates of EGFR in 80 cases of ESCC,the eight cases of squamous epithelial atypical hyperplasia,and eight samples of normal esophageal tissue were 31.3% (25/80),0 (0/8) and 0 (0/8) respectively.In ESCC,EGFR gene amplification was found in 17 (21%) cases,high polysomy in 8 (10%) cases,disomy in 34 cases,low trisomy in 17 cases,and high trisomy in four cases.EGFR FISH-positive was significantly correlated with depth of invasion and lymph node metastasis (P 〈0.05).EGFR FISH-positive was significantly associated with overexpression of EGFR.Conclusion Protein overexpression and/or increased gene copy number of EGFR is common in ESCC,and EGFR targeted therapy may be appropriate for ESCC patients. Background Esophageal squamous cell carcinoma (ESCC) is one of the most frequent malignancies in China and epidermal growth factor receptor (EGFR) is widely distributed in human epithelial cell membrane.The aim of this study was to investigate the protein overexpression and gene copy number of EGFR in ESCC,and help to identify patients who may benefit from EGFR targeted therapies.Methods Immunohistochemistry (IHC) was performed to analyze the expression of EGFR in 105 cases of ESCC,16 cases of squamous epithelial atypical hyperplasia,and 11 cases of normal esophageal tissue.Fluorescence in situ hybridization (FISH) was performed to analyze the gene copy number in 80 cases of ESCC,eight cases of squamous epithelial atypical hyperplasia,and eight samples of normal esophageal tissue.Results The IHC-positive rates of EGFR in 105 cases of ESCC,16 cases of squamous epithelial atypical hyperplasia,and 11 normal esophageal tissues were 97% (102/105),44% (7/16),and 18% (2/11) respectively.The difference in the expression of EGFR among different esophageal tissue groups had statistically significance (P 〈0.05).Among the 105 cases of ESCC,overexpression of EGFR was found in 90 cases (86%),of which 55 cases scored 3+ for EGFR staining and 35 cases scored 2+.In ESCC,the expression of EGFR was significantly correlated with depth of invasion and TNM stage (P〈0.05),but not with other parameters.The FISH-positive rates of EGFR in 80 cases of ESCC,the eight cases of squamous epithelial atypical hyperplasia,and eight samples of normal esophageal tissue were 31.3% (25/80),0 (0/8) and 0 (0/8) respectively.In ESCC,EGFR gene amplification was found in 17 (21%) cases,high polysomy in 8 (10%) cases,disomy in 34 cases,low trisomy in 17 cases,and high trisomy in four cases.EGFR FISH-positive was significantly correlated with depth of invasion and lymph node metastasis (P 〈0.05).EGFR FISH-positive was significantly associated with overexpression of EGFR.Conclusion Protein overexpression and/or increased gene copy number of EGFR is common in ESCC,and EGFR targeted therapy may be appropriate for ESCC patients.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第3期450-454,共5页 中华医学杂志(英文版)
关键词 esophageal squamous cell carcinoma epidermal growth factor receptor IMMUNOHISTOCHEMISTRY fluorescence in situ hybridization esophageal squamous cell carcinoma epidermal growth factor receptor immunohistochemistry fluorescence in situ hybridization
  • 相关文献

参考文献1

同被引文献135

  • 1Lv, Jin,Cao, Xiu-Feng,Zhu, Bin,Ji, Lv,Tao, Lei,Wang, Dong-Dong.Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma[J].World Journal of Gastroenterology,2010,16(13):1649-1654. 被引量:50
  • 2Kyle J Napier,Mary Scheerer,Subhasis Misra.Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities[J].World Journal of Gastrointestinal Oncology,2014,6(5):112-120. 被引量:99
  • 3Andres Castillo,Francisco Aguayo,Chihaya Koriyama,Miyerlandi Torres,Edwin Carrascal,Alejandro Corvalan,Juan P Roblero,Cecilia Naquira,Mariana Palma,Claudia Backhouse,Jorge Argandona,Tetsuhiko Itoh,Karem Shuyama,Yoshito Eizuru,Suminori Akiba.Human papillomavirus in esophageal squamous cell carcinoma in Colombia and Chile[J].World Journal of Gastroenterology,2006,12(38):6188-6192. 被引量:11
  • 4张晓东,沈琳,李洁,李燕,李健,张小田,金懋林.放化疗联合与单独化疗对晚期食管癌生存期影响的比较[J].中华肿瘤杂志,2007,29(6):474-477. 被引量:13
  • 5Scagliotti GV,Parikh P,von Pawel J,Biesma B,Vansteen- kiste J,Manegold C,Serwatowski P,Gatzemeier U,Digumarti R,Zukin M,Lee JS,Mellemgaard A,Park K,Patil S,Rolski J,Goksel T,de Marinis F,Simms L,Sugarman KP,Gandara D.Phase III study comparing cisplatin plus gem- citabine with cisplatin plus pemetrexed in chemotherapy- naive patients with advanced-stage non-small-cell lung can- cer. Journal of Clinical Oncology . 2008
  • 6David J. Adelstein,Cristina P. Rodriguez,Lisa A. Rybicki,Denise I. Ives,Thomas W. Rice.A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction[J]. Investigational New Drugs . 2012 (4)
  • 7Bo Zhang,Yan Wang,Xueli Pang.Enhanced radiosensitivity of EC109 cells by inhibition of HDAC1 expression[J]. Medical Oncology . 2012 (1)
  • 8Kotaro Hirashima MD,Yoshifumi Baba MD, PhD,Masayuki Watanabe MD, PhD,Ryu-ichi Karashima MD,Nobutaka Sato MD,Yu Imamura MD, PhD,Yukiharu Hiyoshi MD, PhD,Yohei Nagai MD,Naoko Hayashi MD, PhD,Ken-ichi Iyama MD, PhD,Hideo Baba MD, PhD.Phosphorylated mTOR Expression is Associated with Poor Prognosis for Patients with Esophageal Squamous Cell Carcinoma[J]. Annals of Surgical Oncology . 2010 (9)
  • 9Kuang-Tai Kuo MD,Hao-Wei Wang MD,Teh-Ying Chou MD, PhD,Wen-Hu Hsu MD,Han-Shui Hsu MD, PhD,Chi-Hung Lin MD, PhD,Liang-Shun Wang MD.Prognostic Role of PGE2 Receptor EP2 in Esophageal Squamous Cell Carcinoma[J]. Annals of Surgical Oncology . 2009 (2)
  • 10Geoffrey Y. Ku,David H. Ilson,Lawrence H. Schwartz,Marinela Capanu,Eileen O’Reilly,Manish A. Shah,David P. Kelsen,Gary K. Schwartz.Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer[J]. Cancer Chemotherapy and Pharmacology . 2008 (5)

引证文献16

二级引证文献84

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部